Related Experiment Videos
An assay for peptide binding to HLA-Cw*0102
M H Andersen1, I Søndergaard, J Zeuthen
1Department of Tumor Cell Biology, Danish Cancer Society, Copenhagen. mha@cancer.dk
Tissue Antigens
|September 17, 1999
Summary
This study adapted a peptide-MHC binding assay for HLA-Cw*0102 molecules. The assay successfully characterized peptide binding affinity, revealing high, intermediate, and non-binding peptides for this important molecule.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Class I Major Histocompatibility Complex (MHC) molecules present peptides to T cells.
- Peptide binding to MHC class I molecules is crucial for immune response.
- Transporter associated with antigen processing (TAP)-deficient cells are used to study MHC assembly.
Purpose of the Study:
- To adapt and validate the peptide-MHC assembly assay for endogenous HLA-Cw*0102 molecules.
- To analyze the binding affinity of specific peptides to HLA-Cw*0102.
- To contribute to understanding HLA-C molecule function in immune surveillance.
Main Methods:
- Utilized a TAP-deficient cell line (T2) for the MHC assembly assay.
- Synthesized and analyzed the binding of 20 peptides with known anchor motifs for HLA-Cw*0102.
- Quantified peptide binding affinity based on the stabilization of HLA-Cw*0102 molecules.
Main Results:
- Successfully adapted the assembly assay for endogenous HLA-Cw*0102.
- One-third of tested peptides exhibited high-affinity binding to HLA-Cw*0102.
- Half of the peptides showed no binding, while the remainder displayed intermediate binding.
Conclusions:
- The peptide-MHC assembly assay is effective for studying HLA-Cw*0102 peptide binding.
- Peptide binding to HLA-Cw*0102 is diverse, with significant variation in affinity.
- This method facilitates further research into HLA-C's role in T cell and NK cell interactions.